Matches in Wikidata for { <http://www.wikidata.org/entity/Q90997307> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q90997307 description "artículu científicu espublizáu en payares de 2019" @default.
- Q90997307 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90997307 description "scientific article published on 28 November 2019" @default.
- Q90997307 description "wetenschappelijk artikel" @default.
- Q90997307 description "наукова стаття, опублікована 28 листопада 2019" @default.
- Q90997307 name "Management of Medication-related Osteonecrosis of the Jaw (MRONJ) risk in patients due to commence anti-resorptive/anti-angiogenic drugs - how should pre-drug-treatment dental preventive care be organised?" @default.
- Q90997307 name "Management of Medication-related Osteonecrosis of the Jaw (MRONJ) risk in patients due to commence anti-resorptive/anti-angiogenic drugs - how should pre-drug-treatment dental preventive care be organised?" @default.
- Q90997307 type Item @default.
- Q90997307 label "Management of Medication-related Osteonecrosis of the Jaw (MRONJ) risk in patients due to commence anti-resorptive/anti-angiogenic drugs - how should pre-drug-treatment dental preventive care be organised?" @default.
- Q90997307 label "Management of Medication-related Osteonecrosis of the Jaw (MRONJ) risk in patients due to commence anti-resorptive/anti-angiogenic drugs - how should pre-drug-treatment dental preventive care be organised?" @default.
- Q90997307 prefLabel "Management of Medication-related Osteonecrosis of the Jaw (MRONJ) risk in patients due to commence anti-resorptive/anti-angiogenic drugs - how should pre-drug-treatment dental preventive care be organised?" @default.
- Q90997307 prefLabel "Management of Medication-related Osteonecrosis of the Jaw (MRONJ) risk in patients due to commence anti-resorptive/anti-angiogenic drugs - how should pre-drug-treatment dental preventive care be organised?" @default.
- Q90997307 P1433 Q90997307-020909A9-BE57-4898-91CE-BC93E984207B @default.
- Q90997307 P1476 Q90997307-C0C593E7-FEBE-4395-A426-C633F9950355 @default.
- Q90997307 P2093 Q90997307-3A461E35-20B6-4837-B4CA-CD8DD994CB9E @default.
- Q90997307 P304 Q90997307-3202C4C3-779F-4013-BD02-098C721EC0E4 @default.
- Q90997307 P31 Q90997307-12c0371c-ba07-4e0a-b671-f1d4d988524e @default.
- Q90997307 P31 Q90997307-6B2132AF-A5D2-47A9-A946-5CF83A2FD22A @default.
- Q90997307 P356 Q90997307-48484E77-A700-4C21-B901-90D65ECDD399 @default.
- Q90997307 P433 Q90997307-F5CC3FCE-F8F4-4C16-B1EF-0A4363D135EE @default.
- Q90997307 P478 Q90997307-FB3FB09C-AF13-4051-9EFB-951C9BB988AF @default.
- Q90997307 P577 Q90997307-B6CC0EBD-312B-4D2B-A3B1-C788D5D22D8B @default.
- Q90997307 P698 Q90997307-F184798A-5FA8-41BD-80CE-01F485B0563E @default.
- Q90997307 P921 Q90997307-5763139F-CD20-415C-8102-CFB4171187F5 @default.
- Q90997307 P356 CDH_4582STEEL11 @default.
- Q90997307 P698 31663693 @default.
- Q90997307 P1433 Q15766896 @default.
- Q90997307 P1476 "Management of Medication-related Osteonecrosis of the Jaw (MRONJ) risk in patients due to commence anti-resorptive/anti-angiogenic drugs - how should pre-drug-treatment dental preventive care be organised?" @default.
- Q90997307 P2093 "B J Steel" @default.
- Q90997307 P304 "244-254" @default.
- Q90997307 P31 Q13442814 @default.
- Q90997307 P31 Q7318358 @default.
- Q90997307 P356 "10.1922/CDH_4582STEEL11" @default.
- Q90997307 P433 "4" @default.
- Q90997307 P478 "36" @default.
- Q90997307 P577 "2019-11-28T00:00:00Z" @default.
- Q90997307 P698 "31663693" @default.
- Q90997307 P921 Q574834 @default.